Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ewa Burchardt
Observed name:
E. Burchardt
Institutions:
Poznan University of Medical Sciences,
Greater Poland Cancer Center
Observed institutions:
Università Cattolica del Sacro Cuore,
Poznan University of Medical Sciences,
Agostino Gemelli University Polyclinic,
Greater Poland Cancer Center
ORCID:
0000-0003-0497-637X
Observed ORCID:
0000-0003-0497-637X
OpenAlex ID:
A5070889098
Impact of the Common Terminology Criteria for Adverse Events (CTCAE) evolution on toxicity scoring in gynaecological radiotherapy
2025
·
Sofia Spampinato
, Kari Tanderup
, et al.
·
Radiotherapy and Oncology
·
24
PDF
Hyperthermia in cervical cancer – current status
2018
·
Ewa Burchardt
, Andrzej Roszak
·
Reports of Practical Oncology & Radiotherapy
·
22
PDF
Influence of Biological Parameters Assessed in [18F]FDG PET/CT on Overall Survival in Cervical Cancer Patients
2019
·
Paulina Cegla
, Ewa Burchardt
, et al.
·
Clinical Nuclear Medicine
·
18
The quality-adjusted life-years in the oncological patients’ health-related quality of life
2022
·
Karolina Kucnerowicz
, Agata Pietrzak
, et al.
·
Scientific Reports
·
10
PDF
Prognostic Value of Pretherapeutic Primary Tumor MTV from [18F]FDG PET in Radically Treated Cervical Cancer Patients
2021
·
Paulina Cegla
, Frank Hofheinz
, et al.
·
Metabolites
·
8
PDF
Influence of 18F-FDG-PET/CT on staging of cervical cancer
2019
·
Paulina Cegla
, Bartosz Urbanski
, et al.
·
Nuklearmedizin - NuclearMedicine
·
7
The effect of different segmentation methods on primary tumour metabolic volume assessed in 18F-FDG-PET/CT in patients with cervical cancer, for radiotherapy planning
2019
·
Paulina Cegła
, Ewa Burchardt
, et al.
·
Współczesna Onkologia
·
7
PDF
Strategy and early results of treatment of advanced cervical cancer patients with synchronous cancers observed in PET-CT imaging
2017
·
Michał Płachta
, Witold Cholewiński
, et al.
·
Ginekologia Polska
·
7
PDF
Asphericity derived from [18F]FDG PET as a new prognostic parameter in cervical cancer patients
2023
·
Paulina Cegla
, Frank Hofheinz
, et al.
·
Scientific Reports
·
6
PDF
Diagnosis and treatment of lung cancer using nuclear medicine techniques — current state of the art
2023
·
Paulina Cegla
, Agnieszka Bos-Liedke
, et al.
·
Nuclear Medicine Review
·
6
PDF
Pretreatment [18F]FDG PET/CT Prognostic Factors in Patients with Squamous Cell Cervical Carcinoma FIGO IIIC1
2021
·
Ewa Burchardt
, Wojciech Burchardt
, et al.
·
Diagnostics
·
6
PDF
Value of [18F]FDG PET/CT radiomic parameters in the context of response to chemotherapy in advanced cervical cancer
2023
·
Ewa Burchardt
, Agnieszka Bos-Liedke
, et al.
·
Scientific Reports
·
5
PDF
The potential of low-dose-rate brachytherapy with iodine-125 in the treatment of local recurrences of prostate cancer after primary high-dose-rate monotherapy
2023
·
Wojciech M. Burchardt
, Artur J. Chyrek
, et al.
·
Journal of Contemporary Brachytherapy
·
5
PDF
Polish Brachytherapy Society clinical recommendations and expert consensus on radical high-dose-rate brachytherapy for prostate cancer
2026
·
Artur J. Chyrek
, Marcin Hetnał
, et al.
·
Journal of Contemporary Brachytherapy
·
3
PDF
Reducing dysphagia with palliative 2D high-dose-rate brachytherapy improves survival in esophageal cancer
2019
·
Wojciech Burchardt
, Artur Chyrek
, et al.
·
Journal of Contemporary Brachytherapy
·
3
PDF
The prognostic value of baseline 18FDG – Positron Emission Tomography – Computed Tomography in cervical cancer patients treated with definitive chemoradiotherapy – External multicentre validation model
2025
·
Emilia Staniewska
, Magdalena Stankiewicz
, et al.
·
Physics and Imaging in Radiation Oncology
·
2
PDF
Differences between [18F]FLT and [18F]FDG Uptake in PET/CT Imaging in CC Depend on Vaginal Bacteriology
2021
·
Ewa Burchardt
, Zaneta Warenczak-Florczak
, et al.
·
Diagnostics
·
2
Tumour-Related Parameters as a Prognostic Factor in Patients with Advanced Cervical Cancer: 20-Year Follow-Up of Diagnostic and Treatment Changes during Chemioradiotherapy
2022
·
Zaneta Warenczak-Florczak
, Ewa Burchardt
, et al.
·
Journal of Personalized Medicine
·
1
PDF
Author Correction: The quality-adjusted life-years in the oncological patients’ health-related quality of life
2022
·
Karolina Kucnerowicz
, Agata Pietrzak
, et al.
·
Scientific Reports
·
1
PDF
Zastosowanie brachyterapii HDR u chorych z rakiem jelita grubego w leczeniu choroby oligometastatycznej w wątrobie – przegląd technik i wskazań.
2018
·
Wojciech Burchardt
, Ewa Burchardt
·
Letters in Oncology Science
·
1
PDF
Rola badania PET w leczeniu raka szyjki macicy w doniesieniach na 3rd ESTRO Forum 2015
2017
·
Ewa Burchardt
·
Letters in Oncology Science
·
1
PDF
PD-0441: Comparison of 18F-FLT PET and 18F-FDG PET in the radiotherapy treatment of cervical cancer
2015
·
E. Burchardt
, P. Cegla
, et al.
·
Radiotherapy and Oncology
·
1
Adverse events in gynaecological radiotherapy: Better Reporting, Interpretation and Dissemination to Generate Evidence (BRIDGE)
2026
·
Sofia Spampinato
, Ewa Burchardt
, et al.
·
Technical Innovations & Patient Support in Radiation Oncology
Validation of [18F]FDG PET-derived and haematological biomarkers for survival prediction in cervical cancer
2026
·
Paulina Cegla
, Geoffrey Currie
, et al.
·
Reports of Practical Oncology & Radiotherapy
PDF
60eP Cemiplimab in recurrent/metastatic cervical cancer: Real-world outcomes from a multicenter Polish-Czech cohort (PCCIG-03 study)
2026
·
R. Pacholczak-Madej
, R. Lupkowski
, et al.
·
ESMO Open
PDF
Show more works
View as search
Works count:
40
Citation count:
146
H-index:
7
I10-index:
4
Year
Topic
Type